Sandra Fuentes

658 total citations
19 papers, 413 citations indexed

About

Sandra Fuentes is a scholar working on Epidemiology, Infectious Diseases and Genetics. According to data from OpenAlex, Sandra Fuentes has authored 19 papers receiving a total of 413 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Epidemiology, 6 papers in Infectious Diseases and 6 papers in Genetics. Recurrent topics in Sandra Fuentes's work include Virus-based gene therapy research (5 papers), Virology and Viral Diseases (4 papers) and Respiratory viral infections research (3 papers). Sandra Fuentes is often cited by papers focused on Virus-based gene therapy research (5 papers), Virology and Viral Diseases (4 papers) and Respiratory viral infections research (3 papers). Sandra Fuentes collaborates with scholars based in United States, Spain and Australia. Sandra Fuentes's co-authors include Biao He, Priya Luthra, Surender Khurana, Kim C. Tran, Michael N. Teng, Elizabeth M. Coyle, Hana Golding, Supriya Ravichandran, Judy A. Beeler and Richard T. Davey and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Medicine and Journal of Virology.

In The Last Decade

Sandra Fuentes

18 papers receiving 406 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Fuentes United States 9 316 205 65 52 49 19 413
Huili Liu China 11 219 0.7× 169 0.8× 36 0.6× 108 2.1× 63 1.3× 60 458
Aizhong Hu Sweden 12 432 1.4× 153 0.7× 65 1.0× 41 0.8× 81 1.7× 17 484
Kelly Watters United States 8 247 0.8× 140 0.7× 104 1.6× 24 0.5× 137 2.8× 9 560
Christina Chommanard United States 7 216 0.7× 354 1.7× 54 0.8× 99 1.9× 15 0.3× 7 502
Jayati Bera United States 13 637 2.0× 233 1.1× 52 0.8× 44 0.8× 70 1.4× 17 745
Federica Pinardi Italy 15 280 0.9× 215 1.0× 33 0.5× 62 1.2× 56 1.1× 24 557
Jérôme Jacques France 12 213 0.7× 228 1.1× 28 0.4× 23 0.4× 56 1.1× 17 418
Kevin W. Graepel United States 7 576 1.8× 481 2.3× 147 2.3× 127 2.4× 56 1.1× 8 809
Laura Klenow United States 12 189 0.6× 258 1.3× 24 0.4× 43 0.8× 57 1.2× 19 457
Peijun Ren China 9 264 0.8× 230 1.1× 48 0.7× 18 0.3× 37 0.8× 13 456

Countries citing papers authored by Sandra Fuentes

Since Specialization
Citations

This map shows the geographic impact of Sandra Fuentes's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Fuentes with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Fuentes more than expected).

Fields of papers citing papers by Sandra Fuentes

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Fuentes. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Fuentes. The network helps show where Sandra Fuentes may publish in the future.

Co-authorship network of co-authors of Sandra Fuentes

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Fuentes. A scholar is included among the top collaborators of Sandra Fuentes based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Fuentes. Sandra Fuentes is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Fuentes, Sandra, et al.. (2023). Study of the diagnostic efficiency of anti-ZnT8 autoantibodies for type 1 diabetes in pediatric patients. Laboratory Medicine. 55(3). 299–303. 1 indexed citations
3.
Fuentes, Sandra, et al.. (2023). Cristales de nitrofuratoína en orina.
4.
Jiménez‐Cortegana, Carlos, Flora Sánchez-Jiménez, Antonio Pérez‐Pérez, et al.. (2023). Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization. Frontiers in Immunology. 14. 1266659–1266659. 1 indexed citations
5.
Jiménez‐Cortegana, Carlos, Flora Sánchez-Jiménez, Antonio Pérez‐Pérez, et al.. (2022). Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19. Frontiers in Immunology. 12. 801410–801410. 10 indexed citations
6.
Fuentes, Sandra, et al.. (2021). Comparison of the analytical and clinical performances of two different routine testing protocols for antinuclear antibody screening. Journal of Clinical Laboratory Analysis. 35(9). e23914–e23914. 4 indexed citations
7.
Fuentes, Sandra, et al.. (2021). Emergency severity level-3 patient flow based on point-of-care testing improves patient outcomes. Clinica Chimica Acta. 523. 144–151. 2 indexed citations
8.
Fuentes, Sandra, Elena Salamanca, J Giron, et al.. (2021). Development and validation of a laboratory-based risk score to predict the occurrence of critical illness in hospitalized patients with COVID-19. Scandinavian Journal of Clinical and Laboratory Investigation. 81(4). 282–289. 3 indexed citations
9.
Fuentes, Sandra, Supriya Ravichandran, Elizabeth M. Coyle, Laura Klenow, & Surender Khurana. (2020). Human Antibody Repertoire following Ebola Virus Infection and Vaccination. iScience. 23(3). 100920–100920. 11 indexed citations
10.
Fuentes, Sandra, Supriya Ravichandran, & Surender Khurana. (2018). Antibody Repertoire of Human Polyclonal Antibodies Against Ebola Virus Glycoprotein Generated After Deoxyribonucleic Acid and Protein Vaccination of Transchromosomal Bovines. The Journal of Infectious Diseases. 218(suppl_5). S597–S602. 5 indexed citations
11.
Khurana, Surender, Sandra Fuentes, Elizabeth M. Coyle, et al.. (2016). Human antibody repertoire after VSV-Ebola vaccination identifies novel targets and virus-neutralizing IgM antibodies. Nature Medicine. 22(12). 1439–1447. 64 indexed citations
12.
Fuentes, Sandra, Diego Arenas, M. H. Moore, Hana Golding, & Surender Khurana. (2016). Development of bioluminescence imaging of respiratory syncytial virus (RSV) in virus-infected live mice and its use for evaluation of therapeutics and vaccines. Vaccine. 35(4). 694–702. 13 indexed citations
13.
Fuentes, Sandra, Elizabeth M. Coyle, Judy A. Beeler, Hana Golding, & Surender Khurana. (2016). Antigenic Fingerprinting following Primary RSV Infection in Young Children Identifies Novel Antigenic Sites and Reveals Unlinked Evolution of Human Antibody Repertoires to Fusion and Attachment Glycoproteins. PLoS Pathogens. 12(4). e1005554–e1005554. 65 indexed citations
14.
Li, Zhuo, Reay G. Paterson, Frank Michel, et al.. (2015). Type II integral membrane protein, TM of J paramyxovirus promotes cell-to-cell fusion. Proceedings of the National Academy of Sciences. 112(40). 12504–12509. 14 indexed citations
15.
Xu, Pei, Priya Luthra, Zhuo Li, et al.. (2011). The V Protein of Mumps Virus Plays a Critical Role in Pathogenesis. Journal of Virology. 86(3). 1768–1776. 27 indexed citations
16.
Li, Zhuo, Jie Xu, Sandra Fuentes, et al.. (2010). Function of the Small Hydrophobic Protein of J Paramyxovirus. Journal of Virology. 85(1). 32–42. 33 indexed citations
17.
Fuentes, Sandra, Kim C. Tran, Priya Luthra, Michael N. Teng, & Biao He. (2007). Function of the Respiratory Syncytial Virus Small Hydrophobic Protein. Journal of Virology. 81(15). 8361–8366. 152 indexed citations
18.
Fuentes, Sandra, et al.. (2001). Serological virus detection (NCM-ELISA) in sweet potato fields at Rio Grande do Sul State, Brazil.. 7(2). 117–119. 2 indexed citations
19.
Acosta, Nidia, María T. Maldonado, Gloria Yaluff, et al.. (1995). Characterization of Paraguayan Trypanosoma cruzi strains isolated from acute patients of Chagas disease.. PubMed. 46(3). 195–200. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026